The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
about
Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine: a single-blinded, placebo-controlled studyGene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinaeErythrocyte and plasma fatty acid patterns in dogs with atopic dermatitis and healthy dogs in the same household.Prevalence of and risk factors for increased serum levels of allergen-specific IgE in a population of Norwegian dogs.Canine atopic dermatitis: validation of recorded diagnosis against practice records in 335 insured Swedish dogsSurvey of dermatological conditions in a population of domestic dogs in Mashhad, northeast of Iran (2007-2011).Prevalence of disorders recorded in dogs attending primary-care veterinary practices in England.Multiple regulatory variants located in cell type-specific enhancers within the PKP2 locus form major risk and protective haplotypes for canine atopic dermatitis in German shepherd dogs.Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis.Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic DrugsLongitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis.Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis.The skin microbiome in healthy and allergic dogs.Survey of otitis externa in American Cocker Spaniels in FinlandAntimicrobial peptides: agents of border protection for companion animals.The genomics revolution: will canine atopic dermatitis be predictable and preventable?Treating canine atopic dermatitis with unsaturated fatty acids: the role of mast cells and potential mechanisms of action.Concise review: Stem cell trials using companion animal disease models.Canine atopic dermatitis: breed risk in Australia and evidence for a susceptible clade.Effect of recombinant canine interferon-γ on granulocyte-macrophage colony-stimulating factor, transforming growth factor-β and CC chemokine ligand 17 mRNA transcription in a canine keratinocyte cell line (CPEK).Prediction of future development of canine atopic dermatitis based on examination of clinical history.Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: a retrospective case-control study.The Influence of long-chain polyunsaturated fatty acids on total lipid fatty acid composition of a canine mastocytoma cell line.Alterations of mast cell mediator production and release by gamma-linolenic and docosahexaenoic acid.Gene (mRNA) expression in canine atopic dermatitis: microarray analysis.Atopic dermatitis and the intestinal microbiota in humans and dogs.The results of intradermal skin tests (IDST) in dogs with atopic dermatitis from the Lublin voivodeship.Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial.Equine intradermal test threshold concentrations for house dust mite and storage mite allergens and identification of stable acari fauna.Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.Use of Accelerometer Activity Monitors to Detect Changes in Pruritic Behaviors: Interim Clinical Data on 6 Dogs.Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study.Urban environment predisposes dogs and their owners to allergic symptoms.Altered expression of antimicrobial peptide genes in the skin of dogs with atopic dermatitis and other inflammatory skin conditions.First report in a dog model of atopic dermatitis: expression patterns of protease-activated receptor-2 and thymic stromal lymphopoietin.Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.Vitamin E supplementation in canine atopic dermatitis: improvement of clinical signs and effects on oxidative stress markers.Major medical causes by breed and life stage for dogs presented at veterinary clinics in the Republic of Korea: a survey of electronic medical records.Characterization of Canine Dendritic Cells in Healthy, Atopic, and Non-allergic Inflamed Skin
P2860
Q33839455-5AEFEDC9-E9B9-4942-83DF-74EDFA946ACCQ34351982-46B52CF5-0F07-4D07-B3BC-1E7B5268BCC3Q34675059-78541CAA-8BB6-43FC-93B9-16CEFD88476DQ34685930-75B302C9-6FF2-488F-9A3D-B7254E08245AQ35005628-E1AA926D-35ED-4D4C-85CD-C224F7BE42A2Q35035379-7E8AA26F-9FE4-42E9-B41D-AF7F93868C77Q35110634-A7668C76-6BC8-464A-8BF5-EE36A96F5534Q36064293-267345DB-20E0-46B1-B15A-86B31623EEB2Q36066892-3643F7AC-9C6C-4050-BC26-9F3645C6F45CQ36795791-02359F06-C026-4563-9A9F-397B569168ABQ36927449-ABBF9ECD-4020-4065-9EF3-31E3E92EDB6EQ36958942-B83E35F2-6C28-43CD-A8DD-D03231803E42Q37452013-F2473F6D-4A56-467B-BC2C-A4CF0BCA8896Q37671403-0A8DB890-1543-4818-BE19-295974B16192Q37992673-A34EFABB-C77D-4722-9CD2-E72FD2A3C923Q38075145-DE40D360-7858-4D57-99AA-A81D17D3EF3CQ38195915-74B2701A-1393-42EC-9262-D45F2B670340Q38804858-A77B0EA1-50E2-4084-B5D2-BD36FF3CAC65Q38836628-3D2D0AFE-9E6D-4E7C-B38F-389FC3F4A157Q39652874-A066ECBC-7273-494E-835F-2D90249DD3F0Q40154101-2AA27A07-611D-4737-BAFE-3DDCB7C06FA2Q40234521-D7032962-F58F-4E0E-BB7F-B3D29A7EFDC5Q40412319-0C4BB912-9CF7-4C8C-9859-7044426A1AB0Q40500813-F5083416-832F-4197-B46F-21753A046A7FQ42648107-CC423B08-C7CC-494E-ACD1-BD517D898AE2Q42682689-1486F090-6472-4E39-B4BA-DBF3141B47F9Q43417744-FDE66826-C370-4D24-8C61-90ADCD6E5DE9Q43469926-70908961-6652-4288-92DB-F368727978A3Q44035082-6739569E-376F-4A0C-8BEF-E92B57308EB0Q44110369-4810C88E-1DAB-4BDE-BAF9-519E2C615779Q45278090-953A861C-2AD1-455B-875A-80249A51AD76Q47562717-F2040D8F-D83A-4E06-A401-C66B43C58C28Q47986677-F4769B26-1EBB-416A-BA6C-0999DB0BA742Q48162739-B362835A-2645-4C1D-865A-8B8D349F0806Q50967870-9A5C7762-3F66-4AD0-9F8C-2BB17D1094C4Q53519318-F4CD9AAD-BFE1-4192-8297-646C7B245D49Q54582351-1D3C45EE-39DF-4B2C-9C3E-6FFA75D30EA2Q55058520-AB49CA96-E1A0-4A35-AF5C-94262D98A202Q55662561-047F8453-E390-4BA5-B611-BC6FC68C70EFQ56775424-97B867A1-D498-4A2F-A31C-3AC6330A5BAA
P2860
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
@ast
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
@en
type
label
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
@ast
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
@en
prefLabel
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
@ast
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
@en
P1476
The ACVD task force on canine atopic dermatitis (I): incidence and prevalence.
@en
P2093
P304
P356
10.1016/S0165-2427(01)00296-3
P577
2001-09-01T00:00:00Z